Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program

Go back to Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program
(NASDAQ: ACHV) Delayed: 5.52 --0 (-0%)
Previous Close $5.52    52 Week High
Open $5.52    52 Week Low
Day High $5.97    P/E N/A 
Day Low $5.49    EPS
Volume 1,172,776